DR LAL PATHLABS
Back to Cashflow Statement
|
DR LAL PATHLABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-264 Cr | ₹-334 Cr | ₹-414 Cr | ₹-283 Cr | ₹136 Cr |
What is the latest Cash Flow from Financing Activities ratio of DR LAL PATHLABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹-264 Cr |
| Mar2025 | ₹-334 Cr |
| Mar2024 | ₹-414 Cr |
| Mar2023 | ₹-283 Cr |
| Mar2022 | ₹136 Cr |
How is Cash Flow from Financing Activities of DR LAL PATHLABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹-264 Cr | Negative | |
| Mar2025 | ₹-334 Cr | Negative | |
| Mar2024 | ₹-414 Cr | Negative | |
| Mar2023 | ₹-283 Cr | Negative | |
| Mar2022 | ₹136 Cr | - | |
Compare Cash Flow from Financing Activities of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹31,672.3 Cr | 2.9% | -2.6% | 25.7% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹121,067.0 Cr | 7.5% | -3.5% | 4.6% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹85,954.5 Cr | 3% | -12.6% | -28.1% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹58,742.0 Cr | 5.4% | -7.1% | -3.9% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹57,376.8 Cr | 5% | -6% | -27.3% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹37,545.2 Cr | 3.5% | -4.6% | -1.1% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | 2.9% |
-2.6% |
25.7% |
| SENSEX | 2.8% |
4.4% |
-10.1% |
You may also like the below Video Courses